138 related articles for article (PubMed ID: 6453301)
41. Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age.
Mann DM; Yates PO; Marcyniuk B; Ravindra CR
J Ment Defic Res; 1985 Jun; 29 ( Pt 2)():125-35. PubMed ID: 2411933
[TBL] [Abstract][Full Text] [Related]
42. Immunocytochemical profile of neurofibrillary tangles in Down's syndrome patients of different ages.
Mann DM; Prinja D; Davies CA; Ihara Y; Delacourte A; Défossez A; Mayer RJ; Landon M
J Neurol Sci; 1989 Sep; 92(2-3):247-60. PubMed ID: 2553874
[TBL] [Abstract][Full Text] [Related]
43. Detection of Lewy bodies in Trisomy 21 (Down's syndrome).
Raghavan R; Khin-Nu C; Brown A; Irving D; Ince PG; Day K; Tyrer SP; Perry RH
Can J Neurol Sci; 1993 Feb; 20(1):48-51. PubMed ID: 8467429
[TBL] [Abstract][Full Text] [Related]
44. A pathological study of the association between Lewy body disease and Alzheimer's disease.
Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
[TBL] [Abstract][Full Text] [Related]
45. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
[TBL] [Abstract][Full Text] [Related]
46. Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease.
Murphy GM; Eng LF; Ellis WG; Perry G; Meissner LC; Tinklenberg JR
Brain Res; 1990 Dec; 537(1-2):102-8. PubMed ID: 1707726
[TBL] [Abstract][Full Text] [Related]
47. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.
Furuta A; Price DL; Pardo CA; Troncoso JC; Xu ZS; Taniguchi N; Martin LJ
Am J Pathol; 1995 Feb; 146(2):357-67. PubMed ID: 7856748
[TBL] [Abstract][Full Text] [Related]
48. Down's syndrome and Alzheimer's disease: dendritic spine counts in the hippocampus.
Ferrer I; Gullotta F
Acta Neuropathol; 1990; 79(6):680-5. PubMed ID: 2141748
[TBL] [Abstract][Full Text] [Related]
49. Neurofibrillary tangles in patients with Down's syndrome: a light and electron microscopic study.
Schochet SS; Lampert PW; McCormick WF
Acta Neuropathol; 1973; 23(4):342-6. PubMed ID: 4268748
[No Abstract] [Full Text] [Related]
50. microRNA 155 up regulation in the CNS is strongly correlated to Down's syndrome dementia.
Tili E; Mezache L; Michaille JJ; Amann V; Williams J; Vandiver P; Quinonez M; Fadda P; Mikhail A; Nuovo G
Ann Diagn Pathol; 2018 Jun; 34():103-109. PubMed ID: 29661714
[TBL] [Abstract][Full Text] [Related]
51. Presenile dementia in Down's syndrome. Ultrastructural identity with Alzheimer's disease.
Ellis WG; McCulloch JR; Corley CL
Neurology; 1974 Feb; 24(2):101-6. PubMed ID: 4272520
[No Abstract] [Full Text] [Related]
52. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
[TBL] [Abstract][Full Text] [Related]
53. Long-term intracerebral transplants of fetal hippocampus from mouse trisomy 16, a model for Down's syndrome (trisomy 21), do not exhibit Alzheimer's disease neuropathology by ultrastructural criteria .
Lane NJ; Balbo A; Stoll J; Rapoport SI
Tissue Cell; 1994 Aug; 26(4):477-88. PubMed ID: 8091421
[TBL] [Abstract][Full Text] [Related]
54. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients.
Ince P; Irving D; MacArthur F; Perry RH
J Neurol Sci; 1991 Dec; 106(2):142-52. PubMed ID: 1802962
[TBL] [Abstract][Full Text] [Related]
55. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases.
Muramori F; Kobayashi K; Nakamura I
Psychiatry Clin Neurosci; 1998 Dec; 52(6):593-9. PubMed ID: 9895207
[TBL] [Abstract][Full Text] [Related]
56. Down's syndrome and Alzheimer's dementia: defining an association.
Heston LL
Psychiatr Dev; 1984; 2(4):287-94. PubMed ID: 6241313
[TBL] [Abstract][Full Text] [Related]
57. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.
Godridge H; Reynolds GP; Czudek C; Calcutt NA; Benton M
J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):775-8. PubMed ID: 2440994
[TBL] [Abstract][Full Text] [Related]
58. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.
Wisniewski KE; Wisniewski HM; Wen GY
Ann Neurol; 1985 Mar; 17(3):278-82. PubMed ID: 3158266
[TBL] [Abstract][Full Text] [Related]
59. The natural history of dementia in Down's syndrome.
Evenhuis HM
Arch Neurol; 1990 Mar; 47(3):263-7. PubMed ID: 2138013
[TBL] [Abstract][Full Text] [Related]
60. Abnormalities of the nucleus basalis in Down's syndrome.
Casanova MF; Walker LC; Whitehouse PJ; Price DL
Ann Neurol; 1985 Sep; 18(3):310-3. PubMed ID: 2932050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
